100 related articles for article (PubMed ID: 2864273)
1. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.
Pimoule C; Schoemaker H; Reynolds GP; Langer SZ
Eur J Pharmacol; 1985 Aug; 114(2):235-7. PubMed ID: 2864273
[No Abstract] [Full Text] [Related]
2. Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
Raisman R; Cash R; Ruberg M; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1985 Jul; 113(3):467-8. PubMed ID: 2864270
[No Abstract] [Full Text] [Related]
3. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
[TBL] [Abstract][Full Text] [Related]
4. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
[TBL] [Abstract][Full Text] [Related]
5. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.
Cash R; Raisman R; Ploska A; Agid Y
J Neurochem; 1987 Oct; 49(4):1075-83. PubMed ID: 2887632
[TBL] [Abstract][Full Text] [Related]
7. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
Kobayashi T; Shimizu H; Toru M
Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
[TBL] [Abstract][Full Text] [Related]
8. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor subtype imbalance in schizophrenia.
Hess EJ; Bracha HS; Kleinman JE; Creese I
Life Sci; 1987 Apr; 40(15):1487-97. PubMed ID: 2951573
[TBL] [Abstract][Full Text] [Related]
10. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
11. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
12. Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
Pimoule C; Schoemaker H; Javoy-Agid F; Scatton B; Agid Y; Langer SZ
Eur J Pharmacol; 1983 Nov; 95(1-2):145-6. PubMed ID: 6667712
[No Abstract] [Full Text] [Related]
13. Differential localization of dopamine D1 and D2 receptors in rat retina.
Tran VT; Dickman M
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
15. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
16. Interaction of flunarizine with dopamine D2 and D1 receptors.
Ambrosio C; Stefanini E
Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
[TBL] [Abstract][Full Text] [Related]
17. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
Gredal O; Parkinson D; Nielsen M
Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
[TBL] [Abstract][Full Text] [Related]
19. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
[TBL] [Abstract][Full Text] [Related]
20. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
Apud JA; Masotto C; Ongini E; Racagni G
Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
